ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.738,17
-0,13%
Dow Jones
42.313,00
0,33%
Euro vs US Dollar
1,11637
-0,11%
Bitcoin
65.762,50
0,89%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Disc Medicine Inc (IRON)

  7. Disc Medicine Inc (IRON) News

IRON

Disc Medicine (IRON)

Disc Medicine Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IRON
DatumZeitQuelleÜberschriftSymbolFirma
19/09/202414h30GlobeNewswire Inc.Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory OfficerNASDAQ:IRONDisc Medicine Inc
18/09/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
16/09/202422h39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
04/09/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
03/09/202422h15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
30/08/202414h00GlobeNewswire Inc.Disc Medicine to Participate in Upcoming Investor ConferencesNASDAQ:IRONDisc Medicine Inc
08/08/202415h23Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:IRONDisc Medicine Inc
08/08/202414h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRONDisc Medicine Inc
08/08/202414h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
08/08/202414h00GlobeNewswire Inc.Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
14/06/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
14/06/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
14/06/202422h01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IRONDisc Medicine Inc
14/06/202414h03GlobeNewswire Inc.Disc Medicine Announces Underwritten Offering of Common StockNASDAQ:IRONDisc Medicine Inc
14/06/202413h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
14/06/202413h30GlobeNewswire Inc.Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
30/05/202415h00GlobeNewswire Inc.Disc Medicine to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRONDisc Medicine Inc
14/05/202416h30GlobeNewswire Inc.Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
13/05/202414h00GlobeNewswire Inc.Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor ConferenceNASDAQ:IRONDisc Medicine Inc
09/05/202414h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRONDisc Medicine Inc
09/05/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
09/05/202414h00GlobeNewswire Inc.Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
01/04/202414h00GlobeNewswire Inc.Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
21/03/202413h00GlobeNewswire Inc.Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
06/03/202422h30GlobeNewswire Inc.Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024NASDAQ:IRONDisc Medicine Inc
02/03/202401h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202401h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202401h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/03/202401h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
26/02/202414h43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:IRON

Kürzlich von Ihnen besucht

USOTC
BASFY
BASF (QX)
NYSE
DIS
Walt Disney
TG
BAS
BASF
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
AMEX
XLF
Financial Select Sector
FX
EURJPY
Euro vs Yen
AMEX
XLV
Health Care Select Sector
TG
ALV
Allianz
COIN
SOLUSD
Solana
TG
CBK
Commerzbank
NYSE
NKE
Nike
NYSE
MRK
Merck
FX
EURUSD
Euro vs US Dollar
TG
DBK
Deutsche Bank
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten